Emergent BioSolutions (EBS) Goodwill impairment charges (2022 - 2023)
Emergent BioSolutions' Goodwill impairment charges came in at $218.2 million for FY2023, compared with $6.7 million in FY2022.
Powered by 
Analysis
Emergent BioSolutions (EBS) Goodwill impairment charges (2022 - 2023) Analysis & Trends
- Per Business Quant, earlier years put Goodwill impairment charges at $6.7 million in FY2022 (-83.9%) and $41.7 million in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,156.80 Bn | 1,125.39 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.73 Bn | 542.26 Bn | 17.26 Bn |
| 3 | AbbVie | 511.53 Bn | 484.64 Bn | 12.70 Bn |
| 4 | Merck | 366.17 Bn | 320.54 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.05 Bn | 261.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.75 Bn | 12.86 Bn |
| 7 | Amgen | 234.26 Bn | 189.66 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.17 Bn | 167.37 Bn | 6.22 Bn |
| 9 | Pfizer | 171.77 Bn | 118.41 Bn | 10.94 Bn |
| 10 | Emergent BioSolutions | 314.76 Mn | -436.14 Mn | 137.20 Mn |
API Access
Emergent BioSolutions Goodwill impairment charges API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "goodwill-impairment-charges", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();